Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study

Saved in:
Bibliographic Details
Published in:JAC-Antimicrobial Resistance
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553967534866433
collection WordPress RSS
FRELIP Feed Integration
container_title JAC-Antimicrobial Resistance
description
discipline_display Internal Medicine
discipline_facet Internal Medicine
format Online Article
RSS Article
genre Journal Article
id rss_article:92281
institution FRELIP
journal_source_facet JAC-Antimicrobial Resistance
last_indexed 2026-06-20T21:45:12.453Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
Internal Medicine
General
Internal Medicine
sub_discipline_display General
sub_discipline_facet General
subject_display Internal Medicine
General
Internal Medicine
subject_facet Internal Medicine
General
Internal Medicine
title Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_alt Utilización de recursos sanitarios y resultados de reingreso en pacientes tratados con ceftolozano/tazobactam: perspectivas del mundo real del estudio multinacional SPECTRA
Utilisation des ressources de soins de santé et résultats de réadmission chez les patients traités par ceftolozane/tazobactam : perspectives réelles de l'étude multinationale SPECTRA
Utilização de recursos de saúde e resultados de readmissão em pacientes tratados com ceftolozano/tazobactam: insights do mundo real do estudo multinacional SPECTRA
title_auth Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_es_txt Utilización de recursos sanitarios y resultados de reingreso en pacientes tratados con ceftolozano/tazobactam: perspectivas del mundo real del estudio multinacional SPECTRA
title_fr_txt Utilisation des ressources de soins de santé et résultats de réadmission chez les patients traités par ceftolozane/tazobactam : perspectives réelles de l'étude multinationale SPECTRA
title_full Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_fullStr Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_full_unstemmed Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_pt_txt Utilização de recursos de saúde e resultados de readmissão em pacientes tratados com ceftolozano/tazobactam: insights do mundo real do estudo multinacional SPECTRA
title_short Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
title_sort healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational spectra study
topic Internal Medicine
General
Internal Medicine
url https://academic.oup.com/jacamr/article/doi/10.1093/jacamr/dlag110/8708783?rss=1